🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This phase I trial studies the side effects and best dose of cabozantinib-s...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2013-05
Trial ID
NCT01835184
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-07-09
Trial ID
NCT01636622
Treatments Being Tested
This phase II trial studies how well atezolizumab in combination with chemo...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-07-27
Trial ID
NCT03181100
Treatments Being Tested
To evaluate the efficacy of vemurafenib in combination with cobimetinib (GD...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-01-08
Trial ID
NCT01689519
Treatments Being Tested
The purpose of this trial is to study the activity of vemurafenib in untrea...
Status
Completed
Location
Smilow Cancer Hospital at Yale New Haven
Start Date
2013-04
Trial ID
NCT01781026
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This trial explores the immunologic effects of vemurafenib (BRAF inhibitor)...
Status
Withdrawn
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2015-08
Trial ID
NCT02427893
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics (PK) of a...
Status
Completed
Location
Magyar Honvedseg Egeszsegugyi Kozpont
Start Date
2015-08-13
Trial ID
NCT02441465
Treatments Being Tested